Confident Investing Starts With TipRanks Premium

Go Ultimate 55% OFF

MX:GLPGN Stock Latest News

Company AnnouncementsLakefront Reports Encouraging Gamgertamig Data in Autoimmune Cytopenias15h ago

Company AnnouncementsLakefront Appoints Drug-Development Veteran Mehdi Shahidi to Board2d ago
Company AnnouncementsLakefront Biotherapeutics Completes €2.85 Million Share Buyback Program2w ago
Company AnnouncementsLakefront Biotherapeutics Sells Cell Therapy Pipeline, Sharpens Focus on T-Cell Engagers3w ago
The FlyLakefront sells early-stage cell therapy pipeline to Armed Cell for $8M upfront3w agoLKFT

Lakefront Biotherapeutics Expands Share Buyback Amid Clinical-Stage Growth

Company AnnouncementsLakefront Biotherapeutics Expands Share Buyback Amid Clinical-Stage Growth3w ago

Company AnnouncementsBank of America trims stake in Lakefront Biotherapeutics below 10% threshold3w ago

Company AnnouncementsLakefront Biotherapeutics Buys Back 117,437 Shares in Ongoing Repurchase Program4w ago

Company AnnouncementsLakefront Biotherapeutics Buys Back Over 100,000 Shares in Ongoing Program1M ago
The FlyMicrosoft upgraded, HubSpot initiated: Wall Street’s top analyst calls1M agoALV ARX
The FlyLakefront upgraded to Outperform from Sector Perform at RBC Capital1M agoLKFT
Company AnnouncementsLakefront Biotherapeutics Steps Up Share Buybacks as Autoimmune Pipeline Advances1M ago

Lakefront Biotherapeutics Expands Share Buyback Amid Strong Capital Position

Company AnnouncementsLakefront Biotherapeutics Expands Share Buyback Amid Strong Capital Position1M ago

Company AnnouncementsLakefront Biotherapeutics boosts buyback as it advances autoimmune pipeline1M ago

Company AnnouncementsLakefront Biotherapeutics Buys Back 127,796 Shares Under Ongoing Repurchase Program2M ago

Company AnnouncementsLakefront Biotherapeutics Buys Back 117,000 Shares in Ongoing Repurchase Program2M ago
Company AnnouncementsBank of America Builds 10% Stake in Lakefront Biotherapeutics Under Belgian Transparency Rules2M ago
The FlyLakefront Biotherapeutics granted orphan drug designation for gamgertamig2M agoGILD LKFT
Company AnnouncementsLakefront Biotherapeutics Expands Share Buyback, Bolstering Capital Strategy2M ago

Lakefront Biotherapeutics price target lowered to $26 from $30 at Morgan Stanley

The FlyLakefront Biotherapeutics price target lowered to $26 from $30 at Morgan Stanley2M agoLKFT

Company AnnouncementsLakefront Biotherapeutics Boosts Immunology Push With Ouro Deal and Strong Cash Outlook2M ago

Pre-EarningsIs 0JXZ a Buy, Before Earnings?2M ago